FEG
GMOV

Fund Evaluation Group’s GMO US Value ETF GMOV Stock Holding History

Fund Evaluation Group’s Portfolio GMOV Stock Details GMOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.38M Hold
80,000
– – 0.06% 52
2026
Q1 		$2.25M Buy
80,000
+29,500
+58% +$841K 0.07% 46
2025
Q4 		$1.39M Buy
50,500
+3,500
+7% +$93.6K 0.05% 42
2025
Q3 		$1.24M Buy
+47,000
New +$1.22M 0.05% 54

Other funds holding GMOV

CA
Commerce Advisors Memphis, Tennessee $184M AUM
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
LCWP
Legacy Capital Wealth Partners Little Rock, Arkansas $521M AUM 28.27% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $217M AUM 47.35% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
JWCA
J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return

Fund Evaluation Group's GMOV Position: Q2 2026 in Review

Fund Evaluation Group held its GMO US Value ETF (GMOV) position steady in Q2 2026 at 80,000 shares worth $2.38M. The position accounts for 0.06% of the portfolio, ranked #52.

Fund Evaluation Group first reported a position in GMOV in Q3 2025 and has held it in 4 quarters since. 20 funds tracked by Wall St. Rank hold GMOV as of Q2 2026.

  • Fund Evaluation Group held 80,000 shares of GMO US Value ETF worth $2.38M as of Q2 2026.
  • Fund Evaluation Group left its GMO US Value ETF share count unchanged in Q2 2026.
  • GMO US Value ETF made up 0.06% of Fund Evaluation Group's portfolio in Q2 2026, its #52 holding.
  • Fund Evaluation Group first reported a position in GMO US Value ETF in Q3 2025 and has held it in 4 quarters since.
  • 20 funds tracked by Wall St. Rank held GMO US Value ETF as of Q2 2026.

Based on Fund Evaluation Group's 13F filing for Q2 2026, filed 7 Aug 2026.